Search

A recent study conducted by researchers at Chulalongkorn University in Bangkok, Thailand, has found that mechanical force plays a significant role in controlling inflammation and immunomodulation in periodontal ligament cells. The periodontal ligament, which is located between the tooth's root and alveolar bone, is constantly subjected to mechanical stimulation through normal or abnormal oral functionality. This mechanical stimulation activates periodontal ligament stem cells (PDLSCs) to modulate periodontal immunity and regulate inflammation. Further research is needed to understand the immunomodulatory features of PDLSCs and develop clinical interventions for periodontal disease. [Extracted from the article]

According to a preprint abstract, Activated PI3K delta syndrome 1 (APDS1) is a genetic condition caused by specific variants in the PIK3CD gene. APDS1 patients experience various clinical manifestations and changes in their T cell populations, including an increase in memory T cells and a decrease in naive T cells. In a mouse model of APDS1, researchers found that dysregulated T cell activation was primarily driven by PI3K GOF T cells, while the increase in Tfh cells was mediated by dysregulated PI3K GOF B cells. The study provides new insights into the clinical phenotype of APDS1 patients and the role of PI3K in immune cells. [Extracted from the article]

According to a preprint abstract, a study aimed to investigate the impact of acute total body irradiation on thymic epithelial cells (TECs), which are important for T cell differentiation and selection. The study found that during the second impact phase, a specific subset of TECs called mTEChi, which express high levels of the co-stimulatory molecule CD80, experienced a significant reduction. RNA sequencing analysis revealed alterations in gene expression profiles in these mTEChi cells, particularly affecting tuft-like TECs and Aire-expressing TECs. These findings suggest that acute total body irradiation can disrupt TEC frequencies and gene expression, potentially compromising thymic functions over extended periods. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the role of Programmed Cell Death Protein-1 (PD-1) in regulating the differentiation of helper T cells. The study found that PD-1 stimulation during the early stage of T cell activation strongly impaired the development of Th2 cells, which are associated with allergic inflammation. In contrast, Th1 cell induction was relatively resistant to this immunosuppressive signaling. The study suggests that PD-1 may not only regulate the intensity but also the quality of immune responses, and PD-1 stimulators could be valuable in suppressing various forms of inflammatory activities, particularly those associated with Th2-dominant immune responses. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the role of the T cell transmembrane receptor CD6 in regulating T cell activation during viral infection. The study found that CD6 deficient mice infected with a neurotropic murine coronavirus showed increased activation and expansion of CD4 T cells in the lymph nodes. Additionally, there was a preferential differentiation of CD4 T cells into T follicular helper cells, resulting in accelerated germinal center responses and the emergence of high affinity virus-specific antibodies. The study suggests that CD6 plays an immunoregulatory role in limiting CD4 T cell activation and deterring CD4 T follicular helper cell differentiation, thereby attenuating antiviral humoral immunity. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

A recent study from St. Jude Children's Research Hospital in Memphis, Tennessee, explores the potential of T cell-based immunotherapy for treating relapsed and refractory cancers. The researchers discuss the limitations of current immunotherapeutic approaches due to cancer's ability to evade the immune system. They also highlight the importance of understanding T cell biology and engineering for developing future cellular therapies. The study provides insights into T cell dysfunction and proposes strategies for improving cancer immunotherapy efficacy. [Extracted from the article]

This article discusses the impact of nutritional iron deficiency on the function of memory T cells following influenza infection. The study, conducted on mice, found that iron deficient mice had decreased systemic iron levels and developed anemia. These mice also experienced increased weight loss and impairments in T cell differentiation and activation during primary influenza infection. Additionally, the iron deficient mice generated increased influenza-specific memory T cells that exhibited impaired ability to produce IFNgamma, particularly within the lung. The study suggests that nutritional iron deficiency can negatively affect T cell memory development and function. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the role of PIM1 and PIM2 kinases in controlling the activation and differentiation of murine CD8 T lymphocytes in response to Interleukin 2 (IL-2) or IL-15 cytokines. The study found that PIM kinases are not necessary for differentiation programs controlled by the antigen-receptor and IL-15, but they do play a selective role in IL-2 regulation of CD8 T cell fate. The PIM kinases were found to control the migratory capabilities of effector CD8 T cells and impact protein synthesis, which in turn shapes cytotoxic T cell proteomes. This study highlights the importance of regulated changes in protein synthesis in influencing T cell phenotypes. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the impact of differential antiviral T cell immunity on the clinical outcome of Cytomegalovirus (CMV) infection in early life. The study found that a deficiency of alpha/beta T cells in early life leads to delayed enrichment of CMV-specific CD8 T cells. The research suggests that defective CD8 T cell immunity may be an important factor in explaining the higher risk for CMV disease in the early-life phase. However, it is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

A recent study conducted at Beth Israel Deaconess Medical Center in Boston, Massachusetts, has found that the protein phosphatase 2A (PP2A) regulatory subunit PPP2R2A plays a role in regulating the immune response in lupus-prone mice. The deficiency of PPP2R2A promotes NAD+ biosynthesis, which inhibits the production of proinflammatory cytokines and promotes the differentiation of regulatory T cells. The study suggests that targeting NAD+ biosynthesis could be a potential therapeutic strategy for lupus. This research was supported by the National Institutes of Health (NIH) in the United States. [Extracted from the article]

According to a preprint abstract, the isoforms Akt1 and Akt2, which are serine threonine kinases, play a crucial role in T cell development. However, their role in peripheral T cell differentiation is not well understood. Using mice with deletions of either Akt1 or Akt2, researchers found that both isoforms are important for Th17 differentiation, with Akt2 loss having a greater impact. Akt2-deficient T cells exhibited enhanced IL-4 production under Th2 polarizing conditions, and Akt2-deficient mice showed diminished IL-17A and GM-CSF production following immunization. These findings suggest that Akt2 is an important signaling molecule in regulating peripheral CD4 T cell responses. [Extracted from the article]

A recent study conducted on T cell differentiation in mice infected with the lymphocytic choriomeningitis virus (LCMV) has provided new insights into the dynamic changes that occur in the T cell proteome during this process. The study utilized proteomic profiling to identify differences in protein abundance between different stages of T cell differentiation, which were not previously highlighted through transcriptional profiling. The findings contribute to a better understanding of T cell differentiation and may have implications for diagnostic and therapeutic approaches. However, it is important to note that this study has not yet undergone peer review. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the role of TIF1g in regulating the stability of T regulatory cells (Tregs) during inflammation. Tregs are important for controlling inflammation and maintaining tissue homeostasis. The study found that TIF1g-deficient Tregs lose stability and acquire an effector phenotype in the presence of inflammation or upon activation. The absence of TIF1g also led to increased methylation in the Foxp3 locus, suggesting a higher susceptibility for loss of Foxp3 expression. The beta-catenin pathway was identified as the molecular mechanism driving TIF1g-dependent Treg stability and proliferation during inflammation. This research provides insights into the modulation of Treg cells for therapeutic purposes. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the role of the epigenetic regulator EZH2 in the pathogenesis of lupus. The study used a mouse model to investigate the effects of deleting Ezh2 in CD4+ T cells. The results showed that Ezh2 deletion prevented lupus-like disease, inhibited T cell differentiation, restricted TCR clonal repertoire, and prevented kidney-infiltrating effector CD4+ T cell expansion and tubulointerstitial nephritis. These findings suggest that targeting EZH2 could be a potential therapeutic strategy for lupus nephritis. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

This article discusses the relationship between two constitutively expressed coinhibitory receptors, CD5 and BTLA, in T cells. The study found that BTLA expression was low in the thymus and high in the periphery, corresponding to high and low CD5 expression, respectively. The researchers demonstrated a causal relationship between BTLA expression and CD5 levels in T cells. They also found that BTLA and another coinhibitory receptor, PD-1, were necessary for establishing self-tolerance in newly generated T cells. The study suggests that the expression of constitutive and induced coinhibitory receptors is important for establishing tolerance in the periphery. [Extracted from the article]

A recent preprint abstract discusses the findings of a study on T cell differentiation in vivo using the lymphocytic choriomeningitis virus (LCMV) mouse model. The study aimed to examine the proteomic profiles of T cell differentiation, which had not been extensively studied before. The researchers found dynamic changes in the T cell proteome during differentiation, with some proteins being significantly abundant in specific cell states that were not previously highlighted by transcriptional profiling. This study provides a comprehensive resource for understanding the proteome of in vivo T cell differentiation and its potential therapeutic implications. However, it is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

This article discusses a clinical trial, NCT06405958, that focuses on analyzing the changes in the microbiome and their impact on prognosis after solid organ transplantation. The microbiome, which can affect the immune system, will be studied by collecting stool samples from transplant recipients. The findings of this study could have implications for transplantation and the potential therapeutic use of modulating the microbiome. The study is not yet recruiting participants and is expected to be completed by December 31, 2026. It is open to individuals of all genders and age groups, and the responsible party is Sei Won Lee from Asan Medical Center. [Extracted from the article]

A recent preprint abstract published on biorxiv.org discusses the findings of a study on the metabolic activity of CD8 T cells during antiviral responses. The researchers used single-cell RNA-sequencing data to estimate metabolic fluxes and observed metabolic variations known from previous studies. They also discovered new sections of CD8 T cell metabolism that are affected by cellular differentiation. The study highlights inter-cellular variability in gene expression levels and a metabolic switch in activated cells transitioning into full-blown effectors. It is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the role of thrombospondin-1 (TSP-1) and thrombospondin-4 (TSP-4) in the formation and function of Supramolecular Attack Particles (SMAPs), which are released by CTLs and NK cells and play a role in cytotoxicity. The study found that TSP-1 is a component of the SMAP shell and contributes to CTL-mediated killing, while TSP-4 has not been investigated in this context. The researchers demonstrated that TSP-4 and TSP-1 have complementary expression profiles during CD8+ T cell differentiation and localize to lytic granules. They also found that TSP-4 is required for TSP-1 association with the granules and is involved in SMAP-mediated cell killing. The study suggests that SMAPs may be a target for immune suppression in chronic lymphocytic leukemia (CLL). However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

A recent study conducted by the Department of Microbiology explores the role of the STING pathway in modulating germinal center responses and CD4 T cell differentiation, which are crucial for establishing long-lasting immunity. The researchers focused on the STING ligand cGAMP and its effects on the differentiation of B cells, plasma cells, and follicular helper T cells, as well as the production of antigen-specific antibodies. The study found that cGAMP enhances the differentiation of B cells and plasma cells, leading to increased antibody production. The findings provide valuable insights that could potentially optimize vaccine efficacy. [Extracted from the article]

A recent study conducted by researchers from the University of Cambridge explores the role of the factor inhibiting HIF (FIH) in T cell function and its potential impact on cancer immunotherapy. The study found that FIH regulates T cell fate and function in a HIF-dependent manner, and inhibiting FIH in T cells may enhance T cell cytotoxicity, T cell expansion, and anti-tumor immunotherapy in mice. The findings suggest that targeting FIH in T cells could be a promising strategy for cancer treatment. The study was funded by various organizations, including the Wellcome Trust and Cancerfonden. [Extracted from the article]

A recent preprint abstract discusses the role of Jag1 insufficiency in disrupting neonatal T cell differentiation and impairing hepatocyte maturation, leading to altered liver fibrosis. The study focuses on Alagille syndrome (ALGS), a condition caused by mutations in the Notch ligand JAGGED1, which results in bile duct paucity, neonatal cholestasis, and fibrotic response. The researchers used a mouse model to study ALGS-like fibrosis and found that Jag1Ndr/Ndr mice exhibited immature hepatocytes and low intrahepatic T cell infiltration. They also observed an enrichment of extrahepatic regulatory T cells (Tregs). Transplanting Jag1Ndr/Ndr lymphocytes into mice resulted in less inflammation and fibrosis compared to Jag1+/+ lymphocytes. The study suggests that Jag1-driven developmental hepatic and immune defects interact to determine the fibrotic process in ALGS. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the role of the epigenetic regulator EZH2 in the pathogenesis of lupus, an autoimmune disease. The study used a mouse model to investigate the effects of deleting Ezh2 in CD4+ T cells. The results showed that Ezh2 deletion prevented lupus-like disease, inhibited T cell differentiation, restricted TCR clonal repertoire, and prevented kidney-infiltrating effector CD4+ T cell expansion and tubulointerstitial nephritis. These findings suggest that targeting EZH2 could be a potential therapeutic strategy for lupus nephritis. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

A recent report from Capital Medical University in Beijing, China, explores the therapeutic effects of celastrol on lupus in MRL/lpr mice. Celastrol, a compound extracted from Tripterygium wilfordii, has shown promise in treating chronic inflammatory and immune disorders. The study found that celastrol reduced the enlargement of the spleen and lymph nodes, alleviated renal injury, and decreased levels of certain antibodies and cytokines. Additionally, celastrol promoted apoptosis of autoimmune T cells and prevented the progression of the autoimmune response. This research provides new insights into potential treatments for lupus. [Extracted from the article]

A new study conducted at Boston Children's Hospital has identified a non-coding single nucleotide polymorphism (SNP) in the CD28/CTLA4/ICOS locus as a risk variant for rheumatoid arthritis and type 1 diabetes. The research found that this risk allele reduces affinity for the inhibitory chromosomal regulator SMCHD1, leading to increased expression of inducible T-cell costimulator (ICOS) in memory CD4+ T cells. This higher expression of ICOS is associated with an increase in circulating T peripheral helper (Tph) cells, which play a role in autoimmune diseases. The study provides insights into the role of ICOS in Tph development and abundance, shedding light on a previously undefined pathway in autoimmunity. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the impact of the LRRK2 G2019S mutation on T-cell functions in Parkinson's Disease (PD). The LRRK2 mutation, which is a genetic risk factor for PD, was found to alter T-cell differentiation in a mouse model. Specifically, T cells derived from mice with the LRRK2 mutation displayed increased Th2 differentiation and decreased Th9 and Treg differentiation. The mutation also affected the expression levels of transcription factors involved in T-cell differentiation and decreased IL-9 production and Treg cell population through the JAK/STAT3 signaling pathway. Further studies are needed to evaluate the impacts of altered T-cell differentiation on dopaminergic neuron damage in PD. [Extracted from the article]

A recent study from Yale University School of Medicine explores the regulation and differentiation of regulatory T (Treg) cells and their dysfunction in autoimmune diseases. The researchers discuss the origins of Treg cells, the mechanisms by which they are induced, and the factors that maintain their suppressive function. They also examine evidence for Treg cell dysfunction in common autoimmune diseases such as multiple sclerosis, inflammatory bowel disease, systemic lupus erythematosus, and rheumatoid arthritis. The study provides valuable insights into the role of Treg cells in autoimmune diseases and highlights the need for further research in this area. [Extracted from the article]

According to a preprint abstract from biorxiv.org, the role of serine/threonine phosphatases in T cell biology is not well understood. The study focused on protein phosphatase 2A (PP2A), which is abundantly expressed in T cells. By deleting the catalytic subunit alpha isoform of PP2A in T cells, the researchers found that it is crucial for the homeostasis and effector functions of CD8+ T cells. PP2A deficiency led to reduced proliferation, survival, and impaired anti-bacterial responses in CD8+ T cells. The study also identified potential targets of PP2A, such as mTORC1 and AKT. It is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

A recent study conducted by researchers at the National Institute on Aging has found that a protein called homeodomain-only protein (HOPX) negatively regulates the activation-induced proliferation of human T cells. The study also revealed that HOPX expression increases with age and that reducing HOPX levels enhances the proliferation of CD8+ T cells in older adults. These findings suggest that HOPX plays a crucial role in T cell differentiation and age-related reduction in T cell proliferation. Further research is needed to fully understand the mechanisms behind these regulatory processes. [Extracted from the article]

A recent study conducted at the University of Houston focused on the role of the faslpr gene in lupus. The researchers developed a new lupus strain and compared it to other strains to evaluate the effects of the gene dosage. The study found that mice with a specific gene dosage exhibited elevated serum antibodies and increased proteinuria, as well as an increased propensity for T cells to differentiate into Th1 cells. The researchers concluded that this new lupus strain is a valuable model for genetic studies and investigating autoimmune responses. [Extracted from the article]

Researchers at the University of Pennsylvania have presented data on cancer, specifically focusing on CD8+ T cells and their role in cancer immunity. The research highlights the importance of CD8+ T cell effector function in effective cancer immunotherapy. The study discusses factors that influence CD8+ T cell differentiation and function in cancer, including the tumor microenvironment. The researchers argue for the concept of immunotherapies as "pro-drugs" that augment or modulate T cells, emphasizing the significance of overall immune health in cancer treatment and prevention. The progress in understanding T cell function in cancer is expected to improve the harnessing of the immune system for the benefit of more patients. [Extracted from the article]

A recent preprint abstract discusses a new approach to tracking the evolution of T cell responses during infection and immunotherapy. The researchers developed a mass cytometric (CyTOF) approach that combines antibodies specific for different T cell receptor (TCR) V- and V{beta}-chains with antibodies against T cell activation and differentiation proteins. This method allows for the identification of expansions of specific T cell subsets and the assessment of cellular function. The researchers used this approach to study T cell responses to Listeria monocytogenes, tumors, and respiratory influenza infection, and found that therapeutic approaches such as vaccination or convalescent serum transfer can alter the clonal diversity and differentiation state of responding T cells. This research has not yet been peer-reviewed. [Extracted from the article]

A recent study explored the relationship between two constitutively expressed coinhibitory receptors, CD5 and BTLA, in T cells. The researchers found that BTLA expression was low in the thymus and high in the periphery, while CD5 expression showed the opposite pattern. Deletion of BTLA in somatic cells demonstrated a causal relationship between BTLA expression and CD5 levels. The study suggests that BTLA may play a role in establishing self-tolerance in newly generated T cells, and its absence can lead to autoimmune disease. However, it is important to note that this research has not yet undergone peer review. [Extracted from the article]

A recent study conducted at the National Defense Medical Center in Taipei, Taiwan, explored the potential benefits of melatonin therapy in preventing encapsulating peritoneal sclerosis (EPS), a severe complication of peritoneal dialysis. The researchers found that melatonin treatment significantly decreased the populations of Th1 and Th17 cells in mice with EPS, while also reducing the production of certain inflammatory cytokines and increasing the production of IL-10. These effects were attributed to the inhibition of dendritic cell activation and the suppression of the NF-xB signaling pathway. The study suggests that melatonin may have preventive potential against EPS in patients with peritoneal dialysis. [Extracted from the article]

A recent report discusses research conducted at the Medical University of Innsbruck in Austria on the metabolism of CD8+ T cells during differentiation and exhaustion. The study found that metabolic reprogramming is crucial for the differentiation process of T cells, and failure to do so can lead to the development of hypofunctional exhausted T cells. The researchers used 13C metabolomics and transcriptomics to study the metabolism of CD8+ T cells and identified various metabolic features that regulate quiescence, proliferation, effector function, and exhaustion. Targeting these metabolic checkpoints may hold promise as a therapeutic strategy for preventing exhaustion and promoting the stemness of anti-tumor T cells. [Extracted from the article]

A recent study conducted by researchers at Kyoto University in Japan explores the potential of using T cells induced from induced pluripotent stem cells (iPSCs) for T cell immunotherapy. The study focuses on the challenges of inducing helper T-iPS-T cells and analyzes T-iPS-T cells matured in 3D organoid culture. The researchers identified candidate genes for the induction of CD4+ T-iPS-T cells and provided single-cell transcriptome datasets for further analysis. This research contributes to the understanding of T cell differentiation from T-iPSCs and its potential applications in immunotherapy. [Extracted from the article]